In the planned follow-up experiment, ADAM10 gene expression level was downregulated, in order to observe the gene and protein expression levels of EGFR and E-cadherin and the influence of the downregulated ADAM10 gene expression level on the proliferation, invasion and migration of the cancer cell line HepG2. The gene discussed is CDH1; the disease is cancer.